Iradimed Co (IRMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Iradimed Co (IRMD) has a cash flow conversion efficiency ratio of 0.063x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($5.92 Million) by net assets ($94.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Iradimed Co - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Iradimed Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Iradimed Co carry for a breakdown of total debt and financial obligations.
Iradimed Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Iradimed Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BrightView Holdings
NYSE:BV
|
0.020x |
|
Luoniushan Co Ltd
SHE:000735
|
0.012x |
|
TUYA INC.ADR/1A
F:785
|
N/A |
|
Sichuan Xunyou Network Technology Co Ltd
SHE:300467
|
0.043x |
|
Jiangsu Riying Electns Co Ltd
SHG:603286
|
0.022x |
|
Zhejiang Great Southeast Co Ltd
SHE:002263
|
-0.002x |
|
Chimera Investment Corporation
NYSE:CIM
|
-0.059x |
|
Changzhou Tronly New Electronic Materials Co Ltd
SHE:300429
|
0.043x |
Annual Cash Flow Conversion Efficiency for Iradimed Co (2012–2025)
The table below shows the annual cash flow conversion efficiency of Iradimed Co from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Iradimed Co (IRMD) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $94.62 Million | $24.95 Million | 0.264x | -10.67% |
| 2024-12-31 | $86.82 Million | $25.62 Million | 0.295x | +56.55% |
| 2023-12-31 | $71.42 Million | $13.47 Million | 0.189x | +38.31% |
| 2022-12-31 | $73.67 Million | $10.04 Million | 0.136x | -12.61% |
| 2021-12-31 | $72.17 Million | $11.26 Million | 0.156x | +64.59% |
| 2020-12-31 | $61.38 Million | $5.82 Million | 0.095x | -48.58% |
| 2019-12-31 | $55.52 Million | $10.23 Million | 0.184x | +4.80% |
| 2018-12-31 | $41.95 Million | $7.38 Million | 0.176x | +69.52% |
| 2017-12-31 | $32.93 Million | $3.42 Million | 0.104x | -64.83% |
| 2016-12-31 | $31.89 Million | $9.41 Million | 0.295x | +23.14% |
| 2015-12-31 | $31.93 Million | $7.65 Million | 0.240x | +93.53% |
| 2014-12-31 | $20.89 Million | $2.59 Million | 0.124x | -54.48% |
| 2013-12-31 | $5.42 Million | $1.47 Million | 0.272x | -41.98% |
| 2012-12-31 | $3.22 Million | $1.51 Million | 0.469x | -- |
About Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring syst… Read more